Stock Ideas

5 Paisa 5 steps to       analyze

Mail to a friend  Feedback

• Siemens reported excellent results for 1QFY02 inspite of recessionary conditions in the economy. It reported a 17% yoy increase in net sales and a 15% yoy increase in total income for 1QFY02. Net profit in 1QFY02 has grown by a healthy 29% yoy. The sales improvement was led by strong performance of the Automation & Drives, Medical Solutions and Power Transmissions & Distribution businesses.

• Operating profit has increased by 33% yoy and OPM also improved from 10.1% to 11.7%. Personnel costs (Rs366m to Rs363m) and other costs (down from Rs426m to Rs421m) have contributed to the improvement in OPM.

• During 1QFY02 new order intake was Rs3.3bn, an increase of 45% yoy. The volume drivers were the Medical Solutions, Power T&D and Automation & Drives businesses. The outstanding order book position as on December 31, 2001 stood at Rs8.33bn (Rs8.2bn in Dec 2000). While order backlog is relatively flat, the company’s order book now has more short lead projects and we are sanguine that its order intake during the year would be healthy.

• A per the ongoing buyback program, the Company bought back shares aggregating Rs465.23m and as a result the shareholding of Siemens AG has gone up to 54.63% from 45.37%.

• As a part of its portfolio restructuring, the company has divested its stake in Siemens Public Communications Network in favor of Siemens AG. Siemens presently has 4,140 employees, a further reduction of about 200 employees in the last one-year. The company is also nearly debt free with debt:equity ratio of 0.01:1.

• At Rs196, the stock is trading at 8.8x annualized FY02E and 10.1xFY01A. Valuations appear attractive and the stock is likely to rally in the near term. We recommend a BUY.

Risks:

• While Automation & Drives and Power segment contribute the maximum to the turnover, the PBIT margins in these businesses are the lowest. Real Estate and Information & Communication are the businesses have the highest margins, but are not the fastest growing businesses.

For detailed results analysis, Click here.

5Paisa Team

Archives

"India Infoline Ltd (IIL) and India Infoline Securities Ltd (IISL) do not have any positions in any of the scrips recommended and which are currently displayed on the site www.indiainfoline.com and www.5paisa.com. IIL and IISL do not do any deals on their own account (proprietary trading) except for testing and demonstration purposes. IIL and IISL also has an internal compliance manual in place which restricts the team who analyze and gives information on various companies and investment opportunities, to place orders on scrips only through IISL and only after the said recommendation has been displayed on the above mentioned websites."